Cargando…

A Case of Parkinson's Disease Treated with Parpanit

Detalles Bibliográficos
Autor principal:	Sanyal, R. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1949
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189449/ https://www.ncbi.nlm.nih.gov/pubmed/15398190

Ejemplares similares

The Diethylaminoethylester of Phenylcyclopentane Carboxylic Acid (Parpanit) Geigy in the Treatment of Diseases of the Extrapyramidal Motor System
Publicado: (1949)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Targeting neurons in the gastrointestinal tract to treat Parkinson's disease()
por: Hauser, Robert A., et al.
Publicado: (2019)

Two Cases of Treponemal Infection Treated with Paritran Preparations. Case 2
por: Sanyal, P. C.
Publicado: (1938)

Sleepiness and Depression in Parkinson’s Disease Patients Treated with Ropinirole and Levodopa
por: Kang, Suk Yun, et al.
Publicado: (2017)

Covid-19 in Parkinson's Disease treated by drugs or brain stimulation
por: Salari, M., et al.
Publicado: (2021)

Mortality in Levodopa-Treated Parkinson's Disease
por: Morgan, John C., et al.
Publicado: (2014)

Recent advances in treating Parkinson’s disease
por: Oertel, Wolfgang H.
Publicado: (2017)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
por: Pauls, K. Amande M., et al.
Publicado: (2021)

Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
por: Huang, Hongli, et al.
Publicado: (2019)

Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
por: Wei, Zhuang-Yao D., et al.
Publicado: (2021)

Interdependence of metals and its binding proteins in Parkinson’s disease for diagnosis
por: Anirudhan, Athira, et al.
Publicado: (2021)

Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol
por: Szejko, Natalia, et al.
Publicado: (2021)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Role of rasagiline in treating Parkinson’s disease: Effect on disease progression
por: Malaty, Irene A, et al.
Publicado: (2009)

Parkinson’s disease or Parkinson symptoms following seasonal influenza
por: Toovey, Stephen, et al.
Publicado: (2011)

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2014)

Patient Preferences for Treating “OFF” Episodes in Parkinson’s Disease: A Discrete Choice Experiment
por: Thach, Andrew, et al.
Publicado: (2021)

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
por: Li, Yan, et al.
Publicado: (2022)

Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
por: Sanchez-Mirasierra, Irene, et al.
Publicado: (2022)

Sleep and risk of parkinsonism and Parkinson’s disease: a population-based study
por: Lysen, Thom S, et al.
Publicado: (2019)

Alexithymia in patients with Parkinson’s disease treated with DBS of the subthalamic nucleus: a case-control study
por: Castelli, Lorys, et al.
Publicado: (2014)

Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease
por: Augustine, Erika F., et al.
Publicado: (2015)

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
por: Vanle, Brigitte, et al.
Publicado: (2018)

An Examination of Mobile Spinal Cord Stimulators on Treating Parkinson Disease
por: Wang, Zhen-Jie, et al.
Publicado: (2021)

Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
por: Benz, Heather L., et al.
Publicado: (2021)

A Case of Acute Endocarditis
por: Sanyal, R. K.
Publicado: (1932)

Caregiver Burden and Quality of Life of Caregivers for Patients with Parkinson’s Disease Treated with Deep Brain Stimulation
por: Gencer, Gökçe Yağmur Güneş, et al.
Publicado: (2023)

Eruptive melanocytic nevi in a patient with Parkinson disease treated by carbidopa-levodopa
por: Haraszti, Samantha, et al.
Publicado: (2018)

Levodopa improves handwriting and instrumental tasks in previously treated patients with Parkinson’s disease
por: Müller, Thomas, et al.
Publicado: (2020)

Professional occupation and the risk of Parkinson's disease
por: Darweesh, S. K. L., et al.
Publicado: (2018)

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson’s disease in Indian population
por: Sanyal, Jaya, et al.
Publicado: (2016)

Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
por: Bajracharya, Rijan, et al.
Publicado: (2019)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease
por: Kong, Min, et al.
Publicado: (2017)

Acupuncture Effect and Mechanism for Treating Pain in Patients With Parkinson's Disease
por: Yu, Shao-Wen, et al.
Publicado: (2019)

Treating Parkinson’s Disease with Antibodies: Previous Studies and Future Directions
por: Castonguay, Anne-Marie, et al.
Publicado: (2021)

Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
por: Liu, Jing, et al.
Publicado: (2020)

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease
por: Delamarre, Anna, et al.
Publicado: (2020)

Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r48plu16q1nn3dtke97hf834pn